Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    WHO wants higher taxes on tobacco, alcohol, and sugary drinks

    4. Juli 2025

    Get 25% off Big Fig mattresses this Fourth of July with our exclusive code

    4. Juli 2025

    Get comfortable and save up to $725 on Serta mattress sets this 4th of July

    4. Juli 2025
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»Gadgets»egnite, Inc. Launches CardioCare Research Suite to Accelerate Patient Identification for Leading Cardiovascular Clinical Trials
    Gadgets

    egnite, Inc. Launches CardioCare Research Suite to Accelerate Patient Identification for Leading Cardiovascular Clinical Trials

    HealthradarBy Healthradar4. Juli 2025Keine Kommentare3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    egnite, Inc. Launches CardioCare Research Suite to Accelerate Patient Identification for Leading Cardiovascular Clinical Trials
    Share
    Facebook Twitter LinkedIn Pinterest Email


    – New Capabilities Automatically Identify Patients for 10 High-Impact Structural Heart and Heart Failure Clinical Trials –

    ALISO VIEJO, Calif.–(BUSINESS WIRE)–#digitalhealth—egnite, Inc., a leading cardiovascular digital health company announced the launch of the CardioCare Research Suite, a significant expansion of its flagship platform designed to streamline and enhance patient identification for clinical trials.

    The Research Suite supports ten landmark clinical trials in structural heart and heart failure care, including AIM-HIGHer, ALT-FLOW II, APOLLO, ARTIST, CLASP IIF, CLASP II TR, CORCINCH-HF, EMPOWER, ENCIRCLE, and PROGRESS.

    This expansion addresses a long-standing challenge in clinical research, ensuring the right patients are surfaced at the right time for trial consideration. Through the use of AI and natural language processing to analyze both structured and unstructured hospital data, the CardioCare Research Suite empowers hospitals to expand access to novel therapies and reduce the operational burden on research teams.

    Early adopters of the Research Suite have reported meaningful results:

    • Over 50% of patients identified through the platform had never been seen by the principal investigator or a relevant specialist.
    • 25%–50% of patient consents were sourced directly from CardioCare.
    • Trial coordinators report significantly less time spent identifying candidates.
    • The platform facilitates more precise, patient-focused outreach by trial investigators, addressing the complexity of evolving eligibility criteria.

    “Since our inception, ambitious programs have expressed a desire to leverage the CardioCare platform to move from passive intake to proactive identification of clinical trial patients,” said Kahla Verhoef, Chief Operating Officer at egnite. “The Research Suite is a direct response to that need, empowering research teams to efficiently surface eligible patients from complex data, align with evolving trial criteria, and engage physicians with precision and confidence.”

    egnite’s CardioCare Research Suite is now an available offering to all partner hospitals using the CardioCare platform. With the ability to leverage AI across structured and unstructured data, the platform uniquely equips research teams to accelerate enrollment and drive clinical innovation forward.

    About egnite, Inc.

    egnite is a data-driven digital health company committed to advancing the health of our society through innovative cardiovascular solutions. egnite utilizes AI algorithms and big data to generate business intelligence for healthcare, elevating the role of data in critical decisions. The company, based in Aliso Viejo, California, partners with leading hospitals and life sciences organizations to transform care delivery for cardiovascular patients. For more information, visit www.egnitehealth.com.

    egnite, egnite, Inc., CardioCare and the spark logo are trademarks of egnite, Inc. All other trademarks are the property of their respective owners.

    Contacts

    Media Contact
    Torrey Loper
    480-467-8685
    torrey.loper@egnitehealth.com





    Source link

    Accelerate CardioCare Cardiovascular Clinical egnite Identification Launches Leading Patient Research Suite Trials
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleCelebrate the 4th of July with up to $700 off at Beautyrest
    Next Article industryGENOME Unveils Groundbreaking Clinical Trial PAO Market Map Report, Powered by AI-Assisted Market Intelligence
    ekass777x
    Healthradar
    • Website

    Related Posts

    Health

    industryGENOME Unveils Groundbreaking Clinical Trial PAO Market Map Report, Powered by AI-Assisted Market Intelligence

    4. Juli 2025
    Gadgets

    Argon AI Raises $5.5M to Build the AI Workspace Powering the Future of Life Sciences

    4. Juli 2025
    Gadgets

    RFK Jr.’s plan to put ‘AI’ in everything is a disaster

    3. Juli 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    New surgeon general nominee cofounded a16z backed health app with DOGE operative

    1. Juni 20257 Views

    Neurode wants to treat and track ADHD symptoms through a wearable headband

    1. Juni 20255 Views

    Whoop wants everyone to give a whoop about the new Whoop 5.0

    1. Juni 20254 Views

    Baby Boomers’ Luck Is Running Out

    14. Juni 20253 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    New surgeon general nominee cofounded a16z backed health app with DOGE operative

    1. Juni 20257 Views

    Neurode wants to treat and track ADHD symptoms through a wearable headband

    1. Juni 20255 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.